Your browser doesn't support javascript.
loading
A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation.
Davids, Matthew S; Kim, Haesook T; Costello, Caitlin; Herrera, Alex F; Locke, Frederick L; Maegawa, Rodrigo O; Savell, Alexandra; Mazzeo, Michael; Anderson, Adrienne; Boardman, Alexander P; Weber, Augustine; Avigan, David; Chen, Yi-Bin; Nikiforow, Sarah; Ho, Vincent T; Cutler, Corey; Alyea, Edwin P; Bachireddy, Pavan; Wu, Catherine J; Ritz, Jerome; Streicher, Howard; Ball, Edward D; Bashey, Asad; Soiffer, Robert J; Armand, Philippe.
Afiliação
  • Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Kim HT; Department of Data Sciences, Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, MA.
  • Costello C; Division of BMT, University of California, San Diego Moores Cancer Center, La Jolla, CA.
  • Herrera AF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA.
  • Locke FL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.
  • Maegawa RO; Eastern Maine Medical Center, Bangor, ME.
  • Savell A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Mazzeo M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Anderson A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Boardman AP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Weber A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Avigan D; BMT Program, Beth Israel Deaconess Medical Center, and.
  • Chen YB; BMT Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
  • Nikiforow S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Ho VT; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Cutler C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Alyea EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Bachireddy P; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Streicher H; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD; and.
  • Ball ED; Division of BMT, University of California, San Diego Moores Cancer Center, La Jolla, CA.
  • Bashey A; Blood and Marrow Transplant Group of Georgia at Northside Hospital, Atlanta, GA.
  • Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Blood ; 135(24): 2182-2191, 2020 06 11.
Article em En | MEDLINE | ID: mdl-32478814
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Antineoplásicos Imunológicos / Nivolumabe Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Antineoplásicos Imunológicos / Nivolumabe Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article